Clinical Trial Update: Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and tolerability of a single inhaler combining beclometasone and formoterol in moderate-to-severe persistent asthma. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Beclometasone/Formoterol (beclometasone/formoterol)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma | Phase 3 | Status: COMPLETED